Showing 98 of 98on this page. Filters & sort apply to loaded results; URL updates for sharing.98 of 98 on this page
Tenpoint Therapeutics launches with $70M Series A financing to reverse ...
Tenpoint Therapeutics Launches with $70 Million Series A Financing to ...
Tenpoint Therapeutics Reports the US FDA Approval of Yuvezzi to Treat ...
Tenpoint Therapeutics Ltd on LinkedIn: #ophthalmology #revolutioninsight
Home - Tenpoint Therapeutics
Tenpoint Therapeutics launches with $70 Million Series A - AlbionVC ...
Tenpoint Therapeutics - 2026 Funding Rounds & List of Investors - Tracxn
Tenpoint Therapeutics launches with focus on regenerative medicine for ...
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial ...
Tenpoint Therapeutics Ltd on LinkedIn: We have an ambitious goal with ...
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for ...
Tenpoint and Visus Therapeutics merge with plans for ophthalmic ...
Tenpoint Therapeutics | Institut de la vision : Rapport d’activité 2023
Tenpoint Therapeutics raises £54m for vision-restoring biotech
Tenpoint Therapeutics names veteran executive as first CCO | Eyes On ...
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial ...
Tenpoint Therapeutics picks up $70M for its regenerative medicine ...
Tenpoint Therapeutics 2026 Company Profile: Valuation, Funding ...
Tenpoint Therapeutics Ltd on LinkedIn: #ophthalmology #biotech #seriesa ...
Tenpoint Therapeutics launches with $70 million in Series A financing
Tenpoint Therapeutics Yuvezzi Eye Drops
Tenpoint Therapeutics announces positive topline results from Phase 3 ...
Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ...
Tenpoint Therapeutics & Visus Therapeutics, Inc. join forces building ...
Tenpoint Therapeutics launches with $70M to restore vision with stem ...
Tenpoint Therapeutics at Stifel Healthcare Conference | Tenpoint ...
TenPoint Therapeutics - Eyewire+
Tenpoint Therapeutics, Visus Therapeutics announce merger
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI ...
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the ...
Tenpoint Therapeutics has recently unveiled promising outcomes from its ...
Tenpoint Therapeutics and clock.bio in EU Start-Ups wins
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces ...
About Us - Tenpoint Therapeutics™
FDA Accepts Tenpoint Therapeutics’ NDA for Brimochol PF for Presbyopia ...
Tenpoint Therapeutics, Ltd. | LinkedIn
Tenpoint Therapeutics, Ltd. and @Visus Therapeutics, Inc. Join Forces ...
Tenpoint Therapeutics, Ltd. on LinkedIn: #tenpointtx #hawaiianeyeandretina
Company News & Press | Tenpoint Therapeutics™
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough ...
Checkpoint Therapeutics Announces Biologics License Application ...
Matchpoint Therapeutics Announces Exclusive Option and License ...
Sun Pharma Acquires Checkpoint Therapeutics for USD 355 Million: Rediff ...
Tenpoint Therapeutics, Ltd. on LinkedIn: #visustx #eyecare #presbyopia ...
South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF ...
#biocapital2025 #biotech | Tenpoint Therapeutics, Ltd.
Press Release: Visus Therapeutics Completes Enrollment in BRIO-I ...
FDA accepts NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia
FDA accepts NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia ...
Exciting time at Tenpoint Therapeutics! Check out our Specialty Sales ...
#tenpointtx #ascrs2025 | Tenpoint Therapeutics, Ltd.
FDA Accepts NDA for Presbyopia Eye Drop BRIMOCHOL PF from Tenpoint ...
Treatments | Tenpoint Therapeutics™
Tenpoint Therapeutics, Ltd. on LinkedIn: AAO 2023: Highlights from the ...
Tenpoint Therapeutics, Ltd. on LinkedIn: #eyecare #presbyopia #visustx ...
Big news at Tenpoint Therapeutics, Ltd.! 🎉 Please join us in giving a ...
Ten Point Logo
Academy 2025 Boston presented by the American Academy of Optometry ...
Ocular Diseases Archives – DHbriefs
FDA accepts Tenpoint's Brimochol PF NDA for presbyopia
BioCentury - Tenpoint: a toolbox of ex vivo and in vivo treatments for ...
T-Therapeutics announces Series A extension to $91 million to advance ...
Tenvie Therapeutics, a Denali spinout, raises $200M as neuro company resets
Tenaya Therapeutics' gene therapy data highlights early heart rhythm ...
Mia Merino, MPH - Senior In-House Clinical Research Associate ...
《國際要聞》翻轉退化性眼疾！Tenpoint獲得7000萬美元投資加速細胞治療臨床期程｜國家新創獎
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
Vision Restoration for Presbyopia, Cataracts, and Geographic Atrophy ...
Review of Ophthalmology – Monthly Publication for Ophthalmologists
